Yun-hao Dai

Taitung, TNQ 40432, Taiwan

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications

In silico identification and biological evaluation of newly synthetic hinokiflavone derivatives as multi-kinase inhibitors with preferential Aurora A activity for ovarian cancer therapy.

In silico identification and biological evaluation of newly synthetic hinokiflavone derivatives as multi-kinase inhibitors with preferential Aurora A activity for ovarian cancer therapy.

Journal: European journal of medicinal chemistry
Published: March 03, 2026

Synergistic effects of Coptis rhizome and rhubarb in inhibiting MDA-MB-231 triple-negative breast cancer metastasis: Potential involvement of coptisine and resveratroloside.

Synergistic effects of Coptis rhizome and rhubarb in inhibiting MDA-MB-231 triple-negative breast cancer metastasis: Potential involvement of coptisine and resveratroloside.

Journal: Fitoterapia
Published: May 05, 2025

Silibinin, a PLC-β3 inhibitor, inhibits mast cell activation and alleviates OVA-induced asthma.

Silibinin, a PLC-β3 inhibitor, inhibits mast cell activation and alleviates OVA-induced asthma.

Journal: Molecular immunology
Published: October 09, 2024

The Efficacy of Lactobacillus delbrueckii ssp. bulgaricus Supplementation in Managing Body Weight and Blood Lipids of People with Overweight: A Randomized Pilot Trial.

The Efficacy of Lactobacillus delbrueckii ssp. bulgaricus Supplementation in Managing Body Weight and Blood Lipids of People with Overweight: A Randomized Pilot Trial.

Journal: Metabolites
Published: November 20, 2023

Effects of Citrus depressa Hayata juice on high-fat diet-induced obesity in HBV transgenic mice.

Effects of Citrus depressa Hayata juice on high-fat diet-induced obesity in HBV transgenic mice.

Journal: Heliyon
Published: October 12, 2023

Drug Screening of Potential Multiple Target Inhibitors for Estrogen Receptor-α-positive Breast Cancer.

Drug Screening of Potential Multiple Target Inhibitors for Estrogen Receptor-α-positive Breast Cancer.

Journal: In vivo (Athens, Greece)
Published: October 21, 2020

19-(Benzyloxy)-19-oxojolkinolide B (19-BJB), an ent-abietane diterpene diepoxide, inhibits the growth of bladder cancer T24 cells through DNA damage.

19-(Benzyloxy)-19-oxojolkinolide B (19-BJB), an ent-abietane diterpene diepoxide, inhibits the growth of bladder cancer T24 cells through DNA damage.

Journal: PloS one
Published: May 07, 2020

ATR-Chk1 signaling inhibition as a therapeutic strategy to enhance cisplatin chemosensitivity in urothelial bladder cancer.

ATR-Chk1 signaling inhibition as a therapeutic strategy to enhance cisplatin chemosensitivity in urothelial bladder cancer.

Journal: Oncotarget
Published: March 11, 2015
Showing 1-8 of 8

Last Updated: 09/26/2026